Heart Failure
Conference Coverage
CardioMEMS boosts QoL, curbs HF hospitalizations: MONITOR-HF
The presentation drew such applause that one chairperson described it as “close to a standing ovation.”
Conference Coverage
Novel antibody safe, promising for ATTR in phase 1 trial
“Ultimately, we are going to need to see a phase 3 clinical trial which shows that NI006 – on top of standard-of-care treatment – improves hard...
From the Journals
Novel insights on Takotsubo syndrome could lead to new therapies
“We believe that it is likely that decreased phosphorylation of myofilament proteins ... may partially account for the impaired contractility and...
From the Journals
Gestational HTN, preeclampsia worsen long-term risk for ischemic, nonischemic heart failure
The current study “is an important step” for its finding that hypertensive disorders of pregnancy are associated separately with both ischemic and...
News from the FDA/CDC
FDA expands use of dapagliflozin to broader range of HF
The sodium-glucose cotransporter 2 inhibitor was previously approved in the United States for adults with heart failure with reduced ejection...
From the Journals
Gut microbiome may guide personalized heart failure therapy
Understanding the gut microbiome and how it may affect development and treatment of heart failure could lead to a more personalized approach to...
From the Journals
Novel strategy could improve heart transplant allocation
The current “six-status” ranking system is under review, and stakeholders propose changes aimed at improving equity and outcomes.
Guidelines
New ACC guidance on heart failure with preserved ejection fraction
The Expert Consensus Decision Pathway offers a framework for diagnosis, clinical decision-making, management of comorbidities, and implementation...
From the Journals
‘Substantial’ variation in responses to BP meds
A new study shows significant variation in the blood pressure response to various antihypertensive medications between individuals.
Guidelines
AHA statement targets nuance in CVD risk assessment of women
Considering nonbiological and social factors when assessing CVD risk in women, particularly women of diverse races and ethnicities, is highlighted...
From the Journals
NSAID use in diabetes may worsen risk for first HF hospitalization
“Given the well-established relationship between the use of NSAIDs and increased HF, these findings are not unexpected because type 2 diabetes is...